4YXR
CRYSTAL STRUCTURE OF PKA IN COMPLEX WITH inhibitor.
4YXR の概要
| エントリーDOI | 10.2210/pdb4yxr/pdb |
| 分子名称 | cAMP-dependent protein kinase catalytic subunit alpha, cAMP-dependent protein kinase inhibitor alpha, 3-methyl-2H-indazole, ... (4 entities in total) |
| 機能のキーワード | complex (phosphotransferase-inhibitor) complex, transferase |
| 由来する生物種 | Bos taurus (Bovine) 詳細 |
| 細胞内の位置 | Cytoplasm : P00517 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 43065.98 |
| 構造登録者 | |
| 主引用文献 | Pilger, J.,Mazur, A.,Monecke, P.,Schreuder, H.,Elshorst, B.,Bartoschek, S.,Langer, T.,Schiffer, A.,Krimm, I.,Wegstroth, M.,Lee, D.,Hessler, G.,Wendt, K.U.,Becker, S.,Griesinger, C. A combination of spin diffusion methods for the determination of protein-ligand complex structural ensembles. Angew.Chem.Int.Ed.Engl., 54:6511-6515, 2015 Cited by PubMed Abstract: Structure-based drug design (SBDD) is a powerful and widely used approach to optimize affinity of drug candidates. With the recently introduced INPHARMA method, the binding mode of small molecules to their protein target can be characterized even if no spectroscopic information about the protein is known. Here, we show that the combination of the spin-diffusion-based NMR methods INPHARMA, trNOE, and STD results in an accurate scoring function for docking modes and therefore determination of protein-ligand complex structures. Applications are shown on the model system protein kinase A and the drug targets glycogen phosphorylase and soluble epoxide hydrolase (sEH). Multiplexing of several ligands improves the reliability of the scoring function further. The new score allows in the case of sEH detecting two binding modes of the ligand in its binding site, which was corroborated by X-ray analysis. PubMed: 25877959DOI: 10.1002/anie.201500671 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






